Full Text View
Tabular View
No Study Results Posted
Related Studies
Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited Genes
This study has been completed.
Study NCT00433641   Information provided by Mayo Clinic
First Received: February 8, 2007   Last Updated: February 17, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Obesity
Additional conditions recognized in this trial
Weight Loss
More general conditions related to this trial
Body Weight
Body Weight Changes
Nutrition Disorders
Overnutrition
Overweight
Signs and Symptoms
Interventions listed in this trial
sibutramine
More general drug interventions related to this trial
Anti-Obesity Agents
Antidepressive Agents
Appetite Depressants
Central Nervous System Agents
Pharmacologic Actions
Psychotropic Drugs
Therapeutic Uses
Sponsors listed in this trial
Mayo Clinic
National Institutes of Health (NIH)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services